Fig. 6
- ID
- ZDB-FIG-231221-55
- Publication
- Zhong et al., 2023 - Zebrafish functional xenograft vasculature platform identifies PF-502 as a durable vasculature normalization drug
- Other Figures
- All Figure Page
- Back to All Figure Page
PF-502 mediates Notch S3 cleavage and activates the Notch signaling pathway in endothelial cells (A) KEGG analysis of the upregulated genes (738) in HUVECs after being treated with PF-502 (0.15 μM for 12 h) highlights the Notch signaling pathway (p < 0.05) (red arrow). (B) Heatmap depicting differentially expressed genes in HUVECs treated with or without PF-502 (0.15 μM for 12 h). (C) RT-PCR analysis of the notch-targeted transcripts DLL4, Notch1, Notch4, Hes1 and Hey2 in HUVECs with or without PF-502 (0.15 μM) treatment for 12 h. Data are expressed as means +SEM. ∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05. Student’s t test. (D) The left panel shows the western blotting (WB) results of (transmembrane Notch (NTM and Notch intracellular domain (NICD) in HUVECs treated with or without PF-502 (0.15 μM) for 24 h. The right panel presents a graph indicating the relative expression levels of NTM and NICD in HUVECs after PF-502 (0.15 μM) treatment for 24 h (n = 3). (E) Maximum intensity projection of the tumor vasculature of the xenografts on 3 dpi on kdrl:EGFP transgenic zebrafish that were treated with γ-secretase inhibitor LY411575 (GSI) (10 μM for 72 h), PF-502(1 μM for 72 h) and combined. The areas in the dotted boxes are magnified below showing vasculature signaling in the gray channel. Scale bars: 50 μm. (F) Percentages of lumenized vessels in xenografts with or without GSI and PF-502 treatment (1 μM for 72 h) (n = 5–7). Data are expressed as means +SEM. ∗∗∗∗p < 0.0001. Student’s t test. (G) WB of NICD in HUVECs with or without drug treatment. LY411575(10 μM for 72 h), PF-502(0.15 μM for 72 h) and combined. (H) Maximum intensity projection of the tumor vasculature of the xenografts on 3 dpi on kdrl:mCherry transgenic zebrafish with indicated notch mutations. Zebrafish were all treated with PF-502 (1 μM for 72 h). Scale bars: 20 μm. (I) Graph showing the percentage of lumenized blood vessels in xenografts at 3 dpi on kdrl:mCherry transgenic zebrafish with the indicated notch mutations treated with PF-502 (1 μM for 72 h). Data are expressed as means +SEM. ∗∗∗∗p < 0.0001, ∗p < 0.05. Student’s t test. |